Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,788 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies.
Nathan AS, Reddy KP, Yang L, Eberly LA, Dayoub EJ, Khatana SAM, Julien HM, Desai ND, Szeto WY, Herrmann HC, Kobayashi TJ, Fiorilli P, Batchelor WB, Mehran R, Alkhouli MA, Giri J, Groeneveld PW, Fanaroff AC. Nathan AS, et al. Among authors: mehran r. JAMA Cardiol. 2023 Feb 1;8(2):120-128. doi: 10.1001/jamacardio.2022.4457. JAMA Cardiol. 2023. PMID: 36477493 Free PMC article.
Echocardiography-guided interventions.
Silvestry FE, Kerber RE, Brook MM, Carroll JD, Eberman KM, Goldstein SA, Herrmann HC, Homma S, Mehran R, Packer DL, Parisi AF, Pulerwitz T, Seward JB, Tsang TS, Wood MA. Silvestry FE, et al. Among authors: mehran r. J Am Soc Echocardiogr. 2009 Mar;22(3):213-31; quiz 316-7. doi: 10.1016/j.echo.2008.12.013. J Am Soc Echocardiogr. 2009. PMID: 19258174 Review.
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.
Chertow GM, Chang AM, Felker GM, Heise M, Velkoska E, Fellström B, Charytan DM, Clementi R, Gibson CM, Goodman SG, Jardine M, Levin A, Lokhnygina Y, Mears J, Mehran R, Stenvinkel P, Wang A, Wheeler DC, Zoccali C, Ridker PM, Mahaffey KW, Tricoci P, Wolf M. Chertow GM, et al. Among authors: mehran r. Nat Med. 2024 May 25. doi: 10.1038/s41591-024-03043-1. Online ahead of print. Nat Med. 2024. PMID: 38796655
Diagnostic Value of Aortic Valve Calcification Levels in the Assessment of Low-Gradient Aortic Stenosis.
Adrichem R, Hokken TW, Bouwmeester S, Abdelkarim O, Vogel B, Blusztein DI, Veulemans V, Kuneman JH, Geleijnse ML, Verhemel S, Van den Dorpel MMP, Kardys I, Tonino PAL, Chang SM, Faza NN, Jou S, Ueyama HA, Bartkowiak J, Zeus T, Bax JJ, Bertrand PB, Hahn RT, Kodali SK, Lerakis S, Mehran R, Little SH, Houthuizen P, Van Mieghem NM. Adrichem R, et al. Among authors: mehran r. JACC Cardiovasc Imaging. 2024 May 10:S1936-878X(24)00129-3. doi: 10.1016/j.jcmg.2024.03.014. Online ahead of print. JACC Cardiovasc Imaging. 2024. PMID: 38795109 Free article.
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.
Cao D, Vranckx P, Valgimigli M, Sartori S, Angiolillo DJ, Bangalore S, Bhatt DL, Feng Y, Ge J, Hermiller J, Makkar RR, Neumann FJ, Saito S, Picon H, Toelg R, Maksoud A, Chehab BM, Choi JW, Campo G, De la Torre Hernandez JM, Krucoff MW, Kunadian V, Sardella G, Spirito A, Thiele H, Varenne O, Vogel B, Zhou Y, Windecker S, Mehran R. Cao D, et al. Among authors: mehran r. EuroIntervention. 2024 May 20;20(10):e630-e642. doi: 10.4244/EIJ-D-23-00658. EuroIntervention. 2024. PMID: 38776146 Free article.
Incidence and Impact of Contrast-Associated Acute Kidney Injury in Patients With High-Bleeding Risk Undergoing Percutaneous Coronary Intervention.
Nicolas J, Pitaro N, Sartori S, Spirito A, Smith KF, Vogel B, Kini A, Dangas G, Sharma SK, Mehran R. Nicolas J, et al. Among authors: mehran r. Circ Cardiovasc Interv. 2024 May;17(5):e013835. doi: 10.1161/CIRCINTERVENTIONS.123.013835. Epub 2024 May 21. Circ Cardiovasc Interv. 2024. PMID: 38771910 No abstract available.
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document.
Garot P, Morice MC, Angiolillo DJ, Cabau JR, Park DW, Van Mieghem NM, Collet JP, Leon MB, Sengottuvelu G, Neylon A, Ten Berg JM, Mylotte D, Tchétché D, Krucoff MW, Reardon MJ, Piazza N, Mack MJ, Généreux P, Makkar R, Hayashida K, Ohno Y, Mochizuki S, Shirai Y, Matsumara R, Jin Y, Webb JG, Cutlip DE, Chen M, Spitzer E, Mehran R, Capodanno D. Garot P, et al. Among authors: mehran r. EuroIntervention. 2024 May 10;20(9):536-550. doi: 10.4244/EIJ-D-23-01020. EuroIntervention. 2024. PMID: 38726720 Free article.
Obicetrapib on Top of Maximally Tolerated Lipid-Modifying Therapies in Participants With or at High Risk for Atherosclerotic Cardiovascular Disease: Rationale and Designs of BROADWAY and BROOKLYN.
Nicholls SJ, Nelson AJ, Ditmarsch M, Kastelein JJP, Ballantyne CM, Ray KK, Navar AM, Nissen SE, Golberg AC, Brunham LR, Curcio D, Wuerdeman E, Neild A, Kling D, Hsieh A, Dicklin MR, Ference BA, Laufs U, Banach M, Mehran R, Catapano AL, Davidson MH. Nicholls SJ, et al. Among authors: mehran r. Am Heart J. 2024 May 3:S0002-8703(24)00116-9. doi: 10.1016/j.ahj.2024.05.002. Online ahead of print. Am Heart J. 2024. PMID: 38705341 Free article.
1,788 results